A Case of Myocarditis Presenting With a Hyperechoic Nodule After the First Dose of COVID-19 mRNA Vaccine
10.3346/jkms.2022.37.e131
- Author:
Seunghwan PARK
1
;
Jihye YOU
Author Information
1. Department of Pediatrics, Jeonbuk National University Children’s Hospital, Jeonju, Korea
- Publication Type:Case Report
- From:Journal of Korean Medical Science
2022;37(16):e131-
- CountryRepublic of Korea
- Language:English
-
Abstract:
Myocarditis and/or pericarditis have been reported as adverse events following coronavirus disease 2019 (COVID-19) messenger RNA vaccination, with most cases occurring within 1 week after the second dose. We report a rare case of myocarditis after the first dose of the BNT162b2 (Pfizer-BioNTech) COVID-19 vaccine in a 17-year-old boy. Here, we describe the laboratory, electrocardiographic, and imaging findings of myocarditis.
